Clinical Trial Update: Expression of TIM-3 and Correlation With Disease Activity in Pediatric Crohn's Disease With Anti TNF-α Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial updating TIM-3 expression and its relationship to disease activity in pediatric Crohn's disease patients treated with anti-TNF-α therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Anti-TNF therapy

Snippet

Sponsor: Samsung Medical Center | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED